Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade

被引:221
作者
Philipp, Sebastian
Yang, Xi-Ming
Cui, Lin
Davis, Amanda M.
Downey, James M.
Cohen, Michael V.
机构
[1] Univ S Alabama, Coll Med, Dept Physiol, Mobile, AL 36688 USA
[2] Univ S Alabama, Coll Med, Dept Med, Mobile, AL 36688 USA
关键词
adenosine receptors; ischemia/reperfusion; NECA; PKC; postconditioning;
D O I
10.1016/j.cardiores.2006.02.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Ischemic postconditioning protects the reperfused heart from infarction, and this protection is dependent on the occupancy of adenosine receptors. We further explored the role of adenosine receptors in this salvage. Methods: In situ rabbit hearts underwent 30min of regional ischemia and 3h of reperfusion, and postconditioning was effected with four cycles of 30-s reperfusion/30-s coronary artery occlusion at the end of ischemia. Results: Postconditioning reduced infarct size from 40.2 +/- 3.4% of the risk zone in untreated hearts to 15.5 +/- 2.5%. Protection by postconditioning was blocked by either the non-selective adenosine receptor blocker 8-p-(sulfophenyl)theophylline or the A(2b)-selective antagonist MRS 1754, injected intravenously 5min before reperfusion. The protein kinase C (PKC) antagonist chelerythrine also aborted postconditioning's salvage, indicating a PKC-dependent mechanism. Neither the A(1)-selective antagonist 8-cyclopentyl-1,3-dipropylxanthine nor the A(2a)-selective antagonist 8-(13-chlorostyryl)caffeine had an effect on protection. The non-selective but A(2b)-potent adenosine agonist 5'-(N-ethylcarboxamido)adenosine (NECA) infused from 5 min before to I h after reperfusion mimicked postconditioning's effect on infarct size (17.2 +/- 2.7% infarction) and MRS 1754 blocked the NECA-induced cardioprotection, confirming that A(2b) activation was protective. The PKC activator phorbol 12-myristate 13-acetate delivered just before reperfusion also duplicated the protective effect of postconditioning (16.3 +/- 4.1% infarction), and co-administration of the PKC antagonist chelerythrine aborted PMA's protection, confirming that the protection was the result of PKC activation. NECA's protective effect was not affected by chelerythrine, but rather MRS 1754 blocked PMA's salutary effect (42.8 +/- 1.0% infarction), suggesting that the A(2b) receptor's effect is under control of PKC. Finally, wortmannin, a blocker of phosphatidylinositol 3-kinase, also abrogated protection by PMA. Conclusions: Salvage of ischemic myocardium by postconditioning is dependent on activation of A(2b) receptors, which in turn depends on activation of PKC. It is still unclear why PKC activation is required to make the heart's adenosine become protective. (c) 2006 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:308 / 314
页数:7
相关论文
共 30 条
[1]   ADENOSINE RECEPTOR-INDUCED CAMP CHANGES IN D384 ASTROCYTOMA-CELLS AND THE EFFECT OF BRADYKININ THEREON [J].
ALTIOK, N ;
BALMFORTH, AJ ;
FREDHOLM, BB .
ACTA PHYSIOLOGICA SCANDINAVICA, 1992, 144 (01) :55-63
[2]   MYOCARDIAL REPERFUSION - A DOUBLE-EDGED SWORD [J].
BRAUNWALD, E ;
KLONER, RA .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (05) :1713-1719
[3]   Protein kinase G transmits the cardioprotective signal from cytosol to mitochondria [J].
Costa, ADT ;
Garlid, KD ;
West, IC ;
Lincoln, TM ;
Downey, JM ;
Cohen, MV ;
Critz, SD .
CIRCULATION RESEARCH, 2005, 97 (04) :329-336
[4]   MYOCARDIAL INFARCT EXTENSION DURING REPERFUSION AFTER CORONARY-ARTERY OCCLUSION - PATHOLOGICAL EVIDENCE [J].
FARB, A ;
KOLODGIE, FD ;
JENKINS, M ;
VIRMANI, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 21 (05) :1245-1253
[5]   Inhibition of δ-protein kinase C protects against reperfusion injury of the ischemic heart in vivo [J].
Inagaki, K ;
Chen, L ;
Ikeno, F ;
Lee, FH ;
Imahashi, K ;
Bouley, DM ;
Rezaee, M ;
Yock, PG ;
Murphy, E ;
Mochly-Rosen, D .
CIRCULATION, 2003, 108 (19) :2304-2307
[6]   Additive protection of the ischemic heart ex vivo by combined treatment with δ-protein kinase C inhibitor and ε-protein kinase C activator [J].
Inagaki, K ;
Hahn, HS ;
Dorn, GW ;
Mochly-Rosen, D .
CIRCULATION, 2003, 108 (07) :869-875
[7]   Adenosine A3 agonist cardioprotection in isolated rat and rabbit hearts is blocked by the A1 antagonist DPCPX [J].
Kilpatrick, EL ;
Narayan, P ;
Mentzer, RM ;
Lasley, RD .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 281 (02) :H847-H853
[8]   Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A2B adenosine receptors [J].
Kim, YC ;
Ji, XD ;
Melman, N ;
Linden, J ;
Jacobson, KA .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (06) :1165-1172
[9]   Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine [J].
Kin, H ;
Zatta, AJ ;
Lofye, MT ;
Amerson, BS ;
Halkos, ME ;
Kerendi, F ;
Zhao, ZQ ;
Guyton, RA ;
Headrick, JP ;
Vinten-Johansen, J .
CARDIOVASCULAR RESEARCH, 2005, 67 (01) :124-133
[10]   ACh and adenosine activate PI3-kinase in rabbit hearts through transactivation of receptor tyrosine kinases [J].
Krieg, T ;
Qin, QN ;
McIntosh, EC ;
Cohen, MV ;
Downey, JM .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2002, 283 (06) :H2322-H2330